Marvin L White

Director; Director, Executive Chair · 2 filings · Latest: Jul 17, 2026

Aptevo Therapeutics Inc.

Emergent BioSolutions Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
APVO	Marvin L White	Director, Executive Chair	Aug 6, 2026	Option Exercise	—	1,666	—	1,667	Aug 11 1:34 AM
APVO	Marvin L White	Director, Executive Chair	Jul 17, 2026	Option Exercise	—	1	—	1	Aug 11 1:34 AM
EBS	White Marvin L	—	Nov 11, 2024	Proposed Sale	$11.77	14,287	$168.2K	—	Nov 12 3:34 PM